NICE methods review: APPG report on access to medicines
Claudia Rubin, Director at Decideum, explores a new publication which will inform the National Institute for Health and Care Excellence (NICE) methods review. So many...
Darren Fergus talks why trust matters
Darren Fergus is Managing Director, Sintetica Ltd, discuses a flat hierarchy, shared values and how trust matters to ensure that employees want to stay. When...
Data-driven marketing in pharma: The future is here
Data-driven marketing in pharma, Pamela Walker and Joshua Hull explain why personalisation is the key to unlocking opportunity via pharma digital marketing. In pharma, ‘digital’...
Pharma and biosimilars in the medicines supply chain
Establishing a firmer position for biosimilars in the medicines supply chain represents a huge opportunity for pharma, the NHS and, most importantly, patients. James...
Ensuring best practice in pharma recruitment
Giles Hampson, Managing director at RMG, discusses what should you consider when hiring to ensure best practice in pharma recruitment? Writing as the Managing Director...
Is pharma addressing the gender pay gap?
Reporting on the gender pay gap is now a requirement for companies of a certain size. How is pharma addressing the gender pay gap...
ABPI guidance on patient engagement
A new sourcebook from the ABPI is clearing the way to greater patient engagement within the confines of the Code of Practice. Ambiguity and confusion...
Winning combination for Roche
Pf speaks to Roche’s Pf Awards 2019 winners, Emma Reynolds who won the Secondary Care Specialist Pf Award 2019 and Julie Van Es who...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...
Building trust in health with sales representatives
Paul Terry explores how the sales representative is best placed to build trust with the health sector, and how industry needs to adapt to...
Latest articles
Mind the generation gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
AstraZeneca presents anifrolumab results from Phase III TULIP trial
Results from the positive Phase III TULIP 2 trial for AstraZeneca's anifrolumab, a potential new medicine for the treatment of moderate to severe systemic...
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Popular articles
Novartis advanced breast cancer treatment approved in Scotland
Novartis’ Kisqali® (ribociclib) in combination with fulvestrant receives recommendation from Scottish Medicines Consortium as advanced breast cancer treatment for patients with the most common...
Mapping NHS change is key to customer engagement
Simon Grime, of Wilmington Healthcare, explains how mapping NHS change through data and intelligence can help industry understand and engage customers in the new...
NHS Commercial Framework for Medicines consultation published
NHS England has published the NHS Commercial Framework for Medicines for consultation. NHS England has a significant role to play in supporting patient access to...
Nurofen launches a 24 hour ibuprofen pain relief patch
Nurofen announces the launch of the UK’s only 24 hour clinically proven pain relief patch containing ibuprofen. Despite body pain being among the most commonly...
Myth busting remote sales solutions
Peter Hyde, Managing Director at Alveo Solutions, looks at the common myths and deciphers the reality of remote sales solutions. The industry is increasingly adopting remote...